Starpharma Pty Limited
Records under this name other than the patents Starpharma Pty Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Back to Starpharma Pty Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,585,387 | PEHAM dendrimers for use in agriculture Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,127,130 | Polylysine dendrimer contrast agent Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,981,858 | Dendrimer and formulations thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,314,920 | Therapeutic Dendrimers Formerly held In force · High confidence | In force | High confidence | |
| US 10,888,624 | Therapeutic Dendrimers Formerly held In force · High confidence | In force | High confidence | |
| US 11,717,574 | Therapeutic Dendrimers Formerly held In force · High confidence | In force | High confidence | |
| US 8,703,116 | Modified macromolecule Term ended Ended no later than May 15, 2026 · From the USPTO record | Term ended | Ended no later than May 15, 2026 | From the USPTO record |
| US 8,568,753 | Delivery system Lapsed on the fee record Ended Oct 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2025 | From the USPTO record |
| US 8,337,823 | Modified macromolecule Lapsed on the fee record Ended Dec 25, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2024 | From the USPTO record |
| US 7,589,056 | Agent for the prevention and treatment of sexually transmitted diseases-I Term ended Term ended Jul 4, 2024 · From the USPTO record | Term ended | Term ended Jul 4, 2024 | From the USPTO record |